-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ES-481 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ES-481 in Epilepsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ES-481 in Epilepsy Drug Details: ES-481 (CERC-611) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ES-009 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ES-009 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ES-009 in Solid Tumor Drug Details: ES-009 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ES-3000 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ES-3000 in Myelodysplastic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ES-3000 in Myelodysplastic Syndrome Drug Details: ES-3000 is under development for...
-
Innovation Ranking
Innovation Ranking – Dottikon ES Holding AG
Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for chemical and pharmaceutical industries. The company finds novel uses for hazardous reactions and continuous processing that facilitate the reduction of chemical synthesis routes, increase output and minimize waste. Dottikon uses its technology to design, develop and optimize chemical processes, and increase production from kilograms to tons. It also offers high-purity isosorbide dimethyl ether, which finds application in cosmetics, pharmaceutical, chemical and agricultural industries....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ES-3000 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ES-3000 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ES-3000 in Acute Myelocytic Leukemia (AML,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ES-481 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ES-481 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ES-481 in Epilepsy Drug Details: ES-481 (CERC-611) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ES-002 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ES-002 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ES-002 in Non-Small Cell Lung Cancer Drug Details: ES-002 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RP-12146 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-12146 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RP-12146 in Pancreatic Cancer Drug Details: RP-12146 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RP-12146 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-12146 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RP-12146 in Gastric Cancer Drug Details: RP-12146 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RP-12146 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-12146 in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RP-12146 in Small-Cell Lung Cancer Drug Details: RP-12146 is under...